Irina Ostrovnaya

11PUBLICATIONS
161CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 09, 2026
Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder Cancer.

Andrew B Katims, Charlie White, Syed Muneeb Alam

|Feb 02, 2026
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran

|Dec 20, 2025
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer.

Ziyu Chen, Xinran Tang, Jordan E Eichholz

|Oct 01, 2024
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma.

Antoine Desilets, Joris L Vos, Nora Katabi

|Jul 01, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer.

Andrew T Lenis, Vignesh Ravichandran, Samantha Brown

|Sep 01, 2022
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort.

Kanika Arora, Thinh N Tran, Yelena Kemel

Pageof 2